These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 19760954)

  • 21. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
    Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation.
    Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Hamba H; Shuto T; Yamamoto T; Ikebe T; Wakasa K
    Hepatogastroenterology; 1999; 46(30):3212-5. PubMed ID: 10626188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
    Takada Y; Otsuka M; Todoroki T; Fukao K
    Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the serum level of soluble E-cadherin in patients with HCC.
    Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
    Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
    Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal fluid contains high concentration of hepatocyte growth factor and vascular endothelial growth factor after resection for hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Lee PH
    Hepatogastroenterology; 2007; 54(75):862-5. PubMed ID: 17591080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
    J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
    Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
    Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
    Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
    Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.